Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate vs Placebo in Pediatric CRMO
NCT07668583Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronate in chronic recurrent multifocal osteomyelitis (CRMO), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
zoledronate
03
Conditions
chronic recurrent multifocal osteomyelitis (CRMO)
Beyond the preview
Go deeper on NCT07668583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668583.